How NSF-funded startups are joining the fight against COVID-19

OmniVis’s rapid disease detection technology is funded by the National Science Foundation (NSF) to develop quick and widespread diagnostics for cholera using our platform. NSF’s SBIR program, also known as America’s Seed Fund, provides early funding for innovative small businesses and we are proud to be part of the community of change-makers. With this new funding, we are excited to join the fight against infectious disease from cholera to applications in COVID-19.